CA-125 Test

What is the CA-125 test, and why is it done? The CA-125 test measures the level of cancer antigen 125 in your blood — a protein that can be elevated in some cancers, particularly ovarian cancer. However, contrary to a common belief, this test is not a reliable screening tool for ovarian cancer in women without symptoms. It is primarily used to monitor how well ovarian cancer treatment is working or to check for recurrence after treatment. Because many benign conditions can also raise CA-125 levels, interpreting the result requires careful evaluation by a gynecologist or oncologist.

What is the CA-125 test and what does it measure?

CA-125 (cancer antigen 125) is a protein produced by certain cells in the body, including those lining the fallopian tubes, ovaries, and the lining of the abdomen (peritoneum). When these cells become cancerous, they may release more CA-125 into the bloodstream. However, non-cancerous conditions — such as endometriosis, uterine fibroids, pelvic inflammatory disease, pregnancy, and even menstruation — can also cause levels to rise.

This test is classified as a tumor marker, not a diagnostic test. A tumor marker gives clues about what might be happening in the body, but it cannot confirm or rule out cancer on its own. Doctors use it alongside imaging (like ultrasound) and sometimes biopsy to make a complete assessment.

When is the CA-125 test ordered?

Doctors typically order CA-125 in these situations:

• Monitoring ovarian cancer treatment: In women already diagnosed with ovarian cancer, serial CA-125 levels help assess whether chemotherapy or surgery is shrinking the tumor.
• Detecting recurrence: After treatment, a rising CA-125 level can be an early sign that the cancer has returned.
• Evaluating a pelvic mass: If an ultrasound or CT scan finds a suspicious mass in the pelvis, CA-125 can provide additional information, especially in postmenopausal women.
• High-risk screening (limited role): In women with a strong family history of ovarian cancer or known BRCA gene mutations, CA-125 combined with transvaginal ultrasound may be used periodically — but this is not routine screening for all women.

It is important to note that CA-125 is not recommended for general population screening, as it misses many early cancers and produces too many false alarms.

What are the limitations of the CA-125 test?

The biggest limitation of the CA-125 test is its lack of specificity. This means a high result does not necessarily mean cancer, and a normal result does not rule out cancer. Here are the key limitations to understand:

• False positives are common: Up to 80% of women with elevated CA-125 who are premenopausal have a benign cause — such as endometriosis, ovarian cysts, fibroids, or pelvic infection. Even being on your period can temporarily raise the level.
• False negatives occur: About 20% of ovarian cancers — especially early-stage ones — do not produce enough CA-125 to be detected. So a normal level cannot give you peace of mind if symptoms are present.
• Not a screening tool: Major health organizations, including the American College of Obstetricians and Gynecologists, advise against using CA-125 alone for routine screening because it does not save lives and can lead to unnecessary invasive procedures.

For these reasons, CA-125 results should always be interpreted in context — your age, menopausal status, symptoms, and imaging findings all matter.

What is the normal range for CA-125?

The typical reference range for CA-125 is below 35 U/mL (units per milliliter). However, laboratories may use slightly different cutoffs, so your report will include the specific range for that lab.

More important than a single number is the trend over time. A level that is rising from 10 to 30 U/mL may be more concerning than a stable 40 U/mL in a woman with known endometriosis. Also, premenopausal women tend to have somewhat higher baseline levels than postmenopausal women.

Key point: A level above 35 U/mL does not mean you have cancer. Many benign conditions cause mild elevations (35–200 U/mL). Strongly elevated levels (e.g., over 200 U/mL) are more suspicious but still require further investigation.

What should I do if my CA-125 level is high?

If your CA-125 test comes back high, here is a rational, step-by-step approach — do not panic:

1. Repeat the test: A single elevated level can be a lab error or due to benign factors. Your doctor may repeat it in 4–6 weeks to see if it changes.
2. Consult a gynecologist: A specialist can evaluate your symptoms, perform a clinical exam, and order appropriate imaging.
3. Imaging: A transvaginal ultrasound (TVS) is the most common next step. It can detect ovarian cysts, fibroids, or other structural issues.
4. Consider other tests: Depending on your situation, your doctor may order a CA-19-9 test (for pancreatic or biliary cancers), a complete blood count, or tumor markers like HE4.
5. Biopsy if needed: If imaging raises suspicion for cancer, a biopsy (tissue sample) is the only way to confirm a diagnosis — CA-125 alone cannot do that.

Remember: in premenopausal women, most elevated results are benign. A high level is a reason for careful evaluation, not a diagnosis.

How much does the CA-125 test cost in Bangladesh?

In Bangladesh, the CA-125 test is available at most private diagnostic labs and hospital-based labs. Prices vary by location, lab reputation, whether the test is done in isolation or as part of a package. Below are typical approximate ranges (in BDT):

These prices are for guidance only. Costs change frequently and differ between Dhaka and other divisions. Always confirm the exact current price with the lab or hospital before proceeding.

Find gynecologist doctors by division in Bangladesh

If you need to discuss your CA-125 results with a specialist, you can find qualified gynecologists and obstetricians across the country using the directory below. Choose your division to connect with experienced doctors who can guide you on next steps.

When to consult a doctor about CA-125 results

You should consult a gynecologist or oncologist if:

• Your CA-125 level came back elevated and you have not spoken to a doctor yet.
• You have symptoms such as bloating, pelvic pain, difficulty eating, or frequent urination — regardless of your CA-125 result.
• You have a family history of ovarian or breast cancer (especially BRCA mutations) and want to understand your risk.
• You have been diagnosed with ovarian cancer and are tracking treatment response.

Never interpret CA-125 results on your own. Only a qualified clinician can integrate the number with your medical history, physical exam, and imaging to give you accurate guidance. Take your report, remain calm, and seek professional advice.

Frequently Asked Questions

Can the CA-125 test be used to diagnose ovarian cancer in women without any symptoms?

No. The CA-125 test is not considered a reliable screening tool for ovarian cancer in the general population of women without symptoms. False positives are common because many benign conditions — such as endometriosis, uterine fibroids, pelvic inflammatory disease, or even menstruation and pregnancy — can also elevate CA-125 levels. Relying on this test alone for early diagnosis would lead to unnecessary anxiety and procedures. It is primarily used to monitor response to treatment or detect recurrence in women already diagnosed with ovarian cancer.

Which benign conditions are most commonly associated with a raised CA-125 level?

Several non-cancerous conditions can cause CA-125 to rise. Common examples include endometriosis, ovarian cysts, uterine fibroids, pelvic inflammatory disease (PID), liver cirrhosis, and even menstruation or pregnancy. This overlap is why a high CA-125 result alone cannot confirm cancer — your doctor will consider your symptoms, imaging results, and possibly repeat testing before drawing conclusions.

How frequently is the CA-125 test repeated during ovarian cancer treatment or follow-up?

Frequency depends on your specific treatment plan and clinical situation. Typically, CA-125 may be measured before each cycle of chemotherapy to see if the level is falling (indicating response), and then every 3–6 months after treatment ends to watch for recurrence. Your oncologist will set a schedule based on your diagnosis and risk factors. Never adjust your treatment timing based on test results without consulting your doctor.

What is the difference between the CA-125 test and other tumour markers like CA 19-9 or CEA?

Each tumour marker is linked to different types of cancer. CA-125 is most associated with ovarian cancer (and some endometrial or fallopian tube cancers). CA 19-9 is often used for pancreatic and biliary tract cancers, while CEA (carcinoembryonic antigen) is common in colorectal cancer. These markers are not interchangeable — a specialist will order the test most relevant to the suspected or known cancer. None of them are absolute diagnostic tests; they provide supportive information alongside imaging and biopsies.

Can diet, exercise, or stress affect my CA-125 level?

There is no strong scientific evidence that normal lifestyle factors like diet or exercise directly cause significant, sustained changes in CA-125 levels. However, temporary mild elevations can occur during menstruation, pregnancy, or with acute infections. Chronic stress has not been proven to raise CA-125 in a meaningful way. If you receive an unexpected high result, do not attribute it to lifestyle changes — consult your doctor promptly for proper evaluation.

Sources

The following sources are from international journals, government health agencies, or recognized medical organizations:

• CA-125 Blood Test – Mayo Clinic (mayoclinic.org)
• Ovarian Cancer – NHS (nhs.uk)
• World Health Organization — CA-125 Test (who.int)
• MedlinePlus — CA-125 Test (medlineplus.gov)
• CDC — CA-125 Test (cdc.gov)
• NHS — CA-125 Test (nhs.uk)